These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7578403)
1. Transfer of the CFTR gene to the lung of nonhuman primates with E1-deleted, E2a-defective recombinant adenoviruses: a preclinical toxicology study. Goldman MJ; Litzky LA; Engelhardt JF; Wilson JM Hum Gene Ther; 1995 Jul; 6(7):839-51. PubMed ID: 7578403 [TBL] [Abstract][Full Text] [Related]
2. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses. Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615 [TBL] [Abstract][Full Text] [Related]
3. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. Wilmott RW; Amin RS; Perez CR; Wert SE; Keller G; Boivin GP; Hirsch R; De Inocencio J; Lu P; Reising SF; Yei S; Whitsett JA; Trapnell BC Hum Gene Ther; 1996 Feb; 7(3):301-18. PubMed ID: 8835218 [TBL] [Abstract][Full Text] [Related]
4. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Engelhardt JF; Litzky L; Wilson JM Hum Gene Ther; 1994 Oct; 5(10):1217-29. PubMed ID: 7849095 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Yang Y; Nunes FA; Berencsi K; Gönczöl E; Engelhardt JF; Wilson JM Nat Genet; 1994 Jul; 7(3):362-9. PubMed ID: 7522742 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Engelhardt JF; Simon RH; Yang Y; Zepeda M; Weber-Pendleton S; Doranz B; Grossman M; Wilson JM Hum Gene Ther; 1993 Dec; 4(6):759-69. PubMed ID: 7514445 [TBL] [Abstract][Full Text] [Related]
7. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Fisher KJ; Choi H; Burda J; Chen SJ; Wilson JM Virology; 1996 Mar; 217(1):11-22. PubMed ID: 8599194 [TBL] [Abstract][Full Text] [Related]
8. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses. Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271 [TBL] [Abstract][Full Text] [Related]
9. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Engelhardt JF; Ye X; Doranz B; Wilson JM Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6196-200. PubMed ID: 8016137 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products. Christ M; Louis B; Stoeckel F; Dieterle A; Grave L; Dreyer D; Kintz J; Ali Hadji D; Lusky M; Mehtali M Hum Gene Ther; 2000 Feb; 11(3):415-27. PubMed ID: 10697116 [TBL] [Abstract][Full Text] [Related]
11. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector. Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924 [TBL] [Abstract][Full Text] [Related]
12. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Sené C; Bout A; Imler JL; Schultz H; Willemot JM; Hennebel V; Zurcher C; Valerio D; Lamy D; Pavirani A Hum Gene Ther; 1995 Dec; 6(12):1587-93. PubMed ID: 8664383 [TBL] [Abstract][Full Text] [Related]
13. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis]. Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273 [TBL] [Abstract][Full Text] [Related]
14. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901 [TBL] [Abstract][Full Text] [Related]
15. Characterization of an adenovirus gene transfer vector containing an E4 deletion. Armentano D; Sookdeo CC; Hehir KM; Gregory RJ; St George JA; Prince GA; Wadsworth SC; Smith AE Hum Gene Ther; 1995 Oct; 6(10):1343-53. PubMed ID: 8590739 [TBL] [Abstract][Full Text] [Related]
16. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Engelhardt JF; Yang Y; Stratford-Perricaudet LD; Allen ED; Kozarsky K; Perricaudet M; Yankaskas JR; Wilson JM Nat Genet; 1993 May; 4(1):27-34. PubMed ID: 7685651 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill. Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885 [TBL] [Abstract][Full Text] [Related]
18. Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration. Nunes FA; Furth EE; Wilson JM; Raper SE Hum Gene Ther; 1999 Oct; 10(15):2515-26. PubMed ID: 10543616 [TBL] [Abstract][Full Text] [Related]
19. Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy. Lerondel S; Le Pape A; Sené C; Faure L; Bernard S; Diot P; Nicolis E; Mehtali M; Lusky M; Cabrini G; Pavirani A Hum Gene Ther; 2001 Jan; 12(1):1-11. PubMed ID: 11177537 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]